All News

New formulation improves safety for patients.

Approved in May 2019, granted to FoldRx, a subsidiary of Pfizer.

Previously approved for IV infusion.

Fourth indication expansion for the 2009 drug.

What to expect for these high-dollar drugs.

Drug able to treat 18,000 people will cost over $300k per year.

Drug shortages might be decreasing, but their continued existence is urging the pharmacy industry to maintain its vigilance.

Available for prescribing starting January 2020

First approved in 2018 for patients 12 years of age and older.

Originally approved in 1995 for use in adults only.

Job growth may stagnate and retail jobs continue to dwindle. 

Results of multi-generational study indicates risk reduction potential.

Study shows that efficacy is a major concern.

What new laws could mean for pharmacies’ role in combatting HIV.

Many cite PBM fees as the primary cause in NCPA survey.

The deal is now official, but the companies have been acting as one for some time.

Administered via a once-daily transdermal patch.

Mothers and babies need the influenza and whooping cough vaccines, CDC says.

New and old non-opioid pain management solutions. 

Currently under DEA review.

Tips for identifying patients with diabetes who need more direction and help.

Patients at-risk for substance abuse more easily identified and managed.

Consumers should stop use and report any adverse events.

How to help manage two of the most common autoimmune diseases.

A surprising look at glucocorticoids and their role in oncology care.

An overview of solid tumors and what differentiates them.

A look at the comorbidities of solid tumors and the methods used to treat them.

One child has already died from complications.